Co-targeting of the PI3K pathway improves the response of BRCA1 deficient breast cancer cells to PARP1 inhibitionSiker Kimbung, Ingrid Hedenfalk, Ewa Biskup et al.|Cancer Letters|2012Cited by 44
Circulating tumor cells in patients with advanced urothelial carcinoma of the bladder: Association with tumor stage, lymph node metastases, FDG-PET findings, and survivalJohan Abrahamsson, Sigurður Guðjónsson, Oliver Patschan et al.|Urologic Oncology Seminars and Original Investigations|2017Cited by 41
Detection of circulating tumor cells and circulating tumor DNA before and after mammographic breast compression in a cohort of breast cancer patients scheduled for neoadjuvant treatmentDaniel Förnvik, Lisa Rydén, Lao H. Saal et al.|Breast Cancer Research and Treatment|2019Cited by 20
292 Circulating tumour cells in patients with advanced urothelial carcinoma of the bladder and correlation with tumour stage, lymph node metastases and FDG-PET-findingsJohan Abrahamsson, Sigurður Guðjónsson, Kristina Aaltonen et al.|European Urology Supplements|2016Cited by 0